Macquarie Group LTD Dexcom Inc Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

A detailed history of Macquarie Group LTD transactions in Dexcom Inc stock. As of the latest transaction made, Macquarie Group LTD holds 2,038,971 shares of DXCM stock, worth $152 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

2,038,971

Previous 2,216,682 8.02%

Holding current value

$152 Million

Previous $307 Million 24.81%

% of portfolio

0.27%

Previous 0.35%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$110.31 - $140.45 $19.6 Million - $25 Million	-177,711 Reduced 8.02%	2,038,971 $231 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $65.8 Million - $80.7 Million	-576,189 Reduced 20.63%	2,216,682 $307 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $18.2 Million - $29.9 Million	-240,608 Reduced 7.93%	2,792,871 $347 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $7.27 Million - $11.7 Million	-84,531 Reduced 2.71%	3,033,479 $283 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $20.5 Million - $23.8 Million	-181,857 Reduced 5.51%	3,118,010 $401 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $17 Million - $20.1 Million	-163,524 Reduced 4.72%	3,299,867 $383 Million
Q4 2022 Feb 21, 2023	SELL	$84.98 - $122.67 $16.3 Million - $23.6 Million	-192,010 Reduced 5.25%	3,463,391 $392 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $28.5 Million - $35.2 Million	373,898 Added 11.39%	3,655,401 $294 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $149 Million - $292 Million	2,195,727 Added 202.23%	3,281,503 $245 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $3.74 Million - $5.18 Million	-39,753 Reduced 3.53%	1,085,776 $555 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $31 Million - $38.8 Million	238,539 Added 26.89%	1,125,529 $604 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $6.72 Million - $9.02 Million	-63,001 Reduced 6.63%	886,990 $485 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $73 Million - $97.3 Million	901,709 Added 1867.59%	949,991 $406 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $131,848 - $162,870	-1,555 Reduced 3.12%	48,282 $17.4 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $485,550 - $650,512	6,225 Added 14.27%	49,837 $18.4 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $199,997 - $236,517	-2,094 Reduced 4.58%	43,612 $18 Million
Q2 2020 Aug 11, 2020	SELL	$62.68 - $105.34 $6.89 Million - $11.6 Million	-109,965 Reduced 70.64%	45,706 $18.5 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $1.32 Million - $2.09 Million	27,574 Added 21.53%	155,671 $41.9 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $1.96 Million - $3.07 Million	-53,577 Reduced 29.49%	128,097 $28 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $133,948 - $165,126	-3,770 Reduced 2.03%	181,674 $27.1 Million
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $295,577 - $413,213	10,617 Added 6.07%	185,444 $27.8 Million
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $239,886 - $326,286	-8,546 Reduced 4.66%	174,827 $20.8 Million
Q4 2018 Feb 15, 2019	SELL	$26.99 - $37.37 $347,496 - $481,138	-12,875 Reduced 6.56%	183,373 $22 Million
Q3 2018 Nov 15, 2018	SELL	$23.35 - $36.72 $936,171 - $1.47 Million	-40,093 Reduced 16.96%	196,248 $28.1 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $523,130 - $752,186	29,825 Added 14.44%	236,341 $22.4 Million
Q1 2018 May 11, 2018	BUY	$13.06 - $18.54 $239,507 - $340,005	18,339 Added 9.75%	206,516 $15.3 Million
Q4 2017 Feb 15, 2018	SELL	$11.12 - $15.38 $456,520 - $631,410	-41,054 Reduced 17.91%	188,177 $10.8 Million
Q3 2017 Nov 08, 2017	BUY	$11.36 - $18.98 $2.6 Million - $4.35 Million	229,231	229,231 $11.2 Million

Others Institutions Holding DXCM

# of Institutions

1,044

Shares Held

354M

Call Options Held

4.08M

Put Options Held

3.81M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.7B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Dexcom Inc Transaction History